ISSN 1662-4009 (online)

ey0020.1-13 | Pediatric Thyroid Cancer | ESPEYB20

1.13. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma

CA Lebbink , TP Links , A Czarniecka , RP Dias , R Elisei , L Izatt , H Krude , K Lorenz , M Luster , K Newbold , A Piccardo , M Sobrinho-Simoes , T Takano , AS Paul van Trotsenburg , FA Verburg , HM van Santen

Brief summary: American Thyroid Association Guidelines for management of children with thyroid nodules and differentiated thyroid cancer were published in 2015 (1). Now Lebbink et al. published management guidelines from the European Thyroid Association.Pediatric differentiated thyroid carcinoma is rare. For many aspects of the disease (diagnosis, treatment, follow-up) clear evidence from randomized controlled trials are therefore missing. The p...

ey0018.3-10 | Congenital hypothyroidism | ESPEYB18

3.10. Cognitive and motor outcome in patients with early-detected central congenital hypothyroidism compared with siblings

JC Naafs , JP Marchal , E Fliers , PH Verkerk , MAJ Luijten , A Boelen , ASP van Trotsenburg , N Zwaveling-Soonawala

J Clin Endocrinol Metab. 2021;106:e1231–e1239. doi: 10.1210/clinem/dgaa901.The results of this study are a robust argument to implement neonatal screening for central congenital hypothyroidism (CCH) worldwide. Only few countries, such as the Netherlands, screen for CCH. Neurodevelopmental outcome data are scarce for CCH compared to primary congenital hypothyroidism (PCH) not only becau...

ey0019.3-4 | Thyroid development | ESPEYB19

3.4. Transcriptomic signature of human embryonic thyroid reveals transition from differentiation to functional maturation

G Dom , P Dmitriev , MA Lambot , Vliet G Van , D Glinoer , F Libert , A Lefort , JE Dumont , C Maenhaut

Front Cell Dev Biol. 2021 Jun 11;9:669354. doi: 10.3389/fcell.2021.669354. eCollection 2021. PMID: 34249923Brief Summary: This in vitro study analyzed the transcriptome of the developing thyroid gland in human embryonic thyroids compared to non-thyroidal human embryonic tissues and adult thyroid and adult non-thyroidal tissues. They identified four differently regulated sets of gen...

ey0019.6-16 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments | ESPEYB19

6.16. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria

Blok CJ de , CM Wiepjes , Velzen DM van , AS Staphorsius , NM Nota , LJ Gooren , BP Kreukels , Heijer M den

Lancet Diabetes Endocrinol. 2021 Oct;9(10):663-670. PMID: 34481559, doi: 10.1016/S2213-8587(21)00185-6. Brief Summary: This paper reports standardised mortality rates (SMR) between 1972 and 2018 in a large cohort of 2927 transgender women and 1641 transgender men from the Amsterdam Cohort of Gender Dysphoria. It finds a higher SMR for transgender women compared with transgender men. </p...

ey0019.9-3 | Metabolic risk in childhood cancer | ESPEYB19

9.3. Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignancies

S Welsch , K Sawadogo , B Brichard , Ville de Goyet M de , Damme A Van , C Boulanger , P Lysy

sophie.welsch@uclouvain.be Diabet Med. 2022; 39: e14720. PMID: 34652870.Brief Summary: Childhood cancer survivors are at increased risk of hyperglycaemia and diabetes due to cancer treatments as asparaginase, steroids and total body irradiation. This single center, retrospective study analyzed the prevalence of hyperglycaemia in 267 patients treated between 2004 and 2019 for hematologic malignancie...

ey0019.14-11 | Risk and Outcome | ESPEYB19

14.11. SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years

Goedegebuure Wesley J. , Van der Steen Manouk , Smeets Carolina CJ , Kerkhof Gerthe F , Hokken-Koelega Anita CS

European Journal of Endocrinology (2022)187:15–26 doi: 10.1530/EJE-21-1130Brief Summary: This study, PROGRAM32, investigated 287 adults mean age 32 years who had participated 10 years earlier in the PROGRAM study on the metabolic and cardiovascular consequences of low birth weight (LBW). The aim was to investigate the adverse metabolic profile of being small for gestational age with spontane...

ey0017.6-20 | Transgender Medicine: Treatment and Cardiovascular Effects | ESPEYB17

6.20. Hormonal treatment and cardiovascular risk profile in transgender adolescents

M Klaver , R de Mutsert , M van der Loos , CM Wiepjes , JWR Twisk , M den Heijer , J Rotteveel , DT Klink

To read the full abstract: Pediatrics. 2020, Mar; 145. doi: https://pediatrics.aappublications.org/content/pediatrics/145/3/e20190741.full.pdfCardiovascular health of transgender people was a hot topic in the transgender literature last year, triggered by previous findings that these individuals could have elevated risks for cardiovascular diseases b...

ey0017.9-12 | Childhood Cancer, Radiation Therapy and Thyroid Disease | ESPEYB17

9.12. Ultrasound is superior to palpation for thyroid cancer detection in high-risk childhood cancer and BMT survivors

J Hess , K Schafernak , D Newbern , T Vern-Gross , J Foote , D Van Tassel , R Jamshidi , A Walsh

To read the full abstract: Support Care Cancer. 2020 Feb 11. Epub ahead of print. hess2@phoenixchildrens.comThe development of a second neoplasia is a major concern during the follow-up of childhood cancer survivors (CCS). Secondary cancers account for nearly 50% of non-relapse mortality at 5 years. Thyroid tumours represent 10-20% of subsequent neoplasia cases, due to the high sensitivity of the g...

ey0016.4-4 | Important for Clinical Practice | ESPEYB16

4.4. Phenotypic features and response to growth hormone treatment of patients with a molecular defect of the IGF-1 receptor

MJE Walenkamp , JML Robers , JM Wit , GRJ Zandwijken , HA van Duyvenvoorde , W Oostdijk , ACS Hokken-Koelega , SG Kant , M Losekoot

To read the full abstract: J Clin Endocrinol Metab. 2019; 104(8): 3157–3171.The IGF receptor gene IGF1R is located at 15q26.3 locus and encodes for a tyrosine kinase receptor which mediates the IGF-I biological actions. The key role of IGF-IR in growth and development was proved in IGF1R null mice that had severely impaired prenatal growth and invariably died at birth ...

ey0015.4-4 | Important for clinical practice | ESPEYB15

4.4 Consensus Based Definition of Growth Restriction in the Newborn

IM Beune , FH Bloomfield , W Ganzevoort , ND Embleton , PJ Rozance , AG van Wassenaer-Leemhuis , K Wynia , SJ Gordijn

To read the full abstract: J Pediatr 2018. 196:71-76Fetal growth restriction describes a fetus who fails to achieve their biological growth potential, remaining smaller than its genetic potential, and occurs in ~10% of pregnancies [22]. FGR and SGA are terms that are often and wrongly used in an interchangeable way. SGA does not inevitably entail a pathological condition, b...